Primidone
Primidone is an anticonvulsant medicine primarily used to treat epilepsy, particularly focal and generalised tonic-clonic seizures. It is also used to manage essential tremor, helping reduce involuntary shaking of the hands and other body parts. It works through its own anticonvulsant activity and by conversion into active metabolites, including phenobarbital, which enhance inhibitory signalling in the central nervous system. It is commonly available as oral tablets or suspension, depending on the market and formulation. Common side effects include drowsiness, dizziness, nausea, fatigue, and impaired coordination. Important risks include dependence, withdrawal seizures following abrupt discontinuation, blood disorders, and mood or behavioural changes. Treatment should be initiated and adjusted under medical supervision, and the medicine should not be stopped suddenly.
Primidone was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Primidone, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Primidone from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Primidone, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
